| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,039 |
5,627 |
$442K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,992 |
2,732 |
$261K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,185 |
1,160 |
$107K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,061 |
1,054 |
$97K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
776 |
769 |
$76K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,260 |
2,226 |
$46K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
531 |
519 |
$45K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,185 |
1,152 |
$36K |
| 99215 |
Prolong outpt/office vis |
306 |
278 |
$33K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,736 |
2,698 |
$28K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
908 |
820 |
$23K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,015 |
1,988 |
$19K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
994 |
987 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
181 |
173 |
$9K |
| 99442 |
|
318 |
264 |
$6K |
| 0071A |
|
103 |
94 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
477 |
468 |
$4K |
| 0072A |
|
82 |
81 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
154 |
146 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
24 |
24 |
$2K |
| 90461 |
|
418 |
407 |
$2K |
| 96127 |
|
361 |
354 |
$2K |
| 87430 |
|
98 |
94 |
$1K |
| 85018 |
|
346 |
336 |
$737.30 |
| 81002 |
|
235 |
232 |
$603.91 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
35 |
32 |
$476.17 |
| 94760 |
|
129 |
107 |
$272.38 |
| 94664 |
|
16 |
13 |
$162.96 |
| 90686 |
|
1,182 |
1,160 |
$18.00 |
| 99000 |
|
833 |
739 |
$0.00 |
| 90698 |
|
78 |
70 |
$0.00 |
| 90680 |
|
61 |
61 |
$0.00 |
| 90620 |
|
40 |
40 |
$0.00 |
| 91307 |
|
216 |
188 |
$0.00 |
| 36416 |
|
17 |
17 |
$0.00 |
| 90697 |
|
28 |
27 |
$0.00 |
| 90744 |
|
14 |
14 |
$0.00 |
| 90651 |
|
37 |
37 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
12 |
12 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
16 |
13 |
$0.00 |
| 90688 |
|
51 |
51 |
$0.00 |
| 90734 |
|
25 |
25 |
$0.00 |
| 90670 |
|
227 |
225 |
$0.00 |
| 90633 |
|
37 |
36 |
$0.00 |
| 90671 |
|
16 |
16 |
$0.00 |